Trial
NCT02814019
A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Santhera Pharmaceuticals
Collaborators
—
Condition
Duchenne Muscular Dystrophy (DMD)
Intervention
Idebenone 150 mg film-coated tablets
Why stopped
Interim analysis concluded to futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-12-03